Human papillomavirus: What every provider should know

American Journal of Obstetrics and Gynecology

Volumn 208, Issue 3, 2013, Pages 169-175

  Erickson, Britt K ^a   Alvarez, Ronald D ^a   Huh, Warner K ^a  

^a UNIVERSITY OF ALABAMA AT BIRMINGHAM   (United States)

Author keywords

cervical cancer screening; human papillomavirus; human papillomavirus biology; human papillomavirus testing; human papillomavirus vaccination

Indexed keywords

WART VIRUS VACCINE;

ARTICLE; CIRCUMCISION; COLPOSCOPY; FEMALE; FOLLOW UP; GENOTYPE; HUMAN; LIFE CYCLE; NONHUMAN; PAPANICOLAOU TEST; PAPILLOMAVIRUS INFECTION; PREVALENCE; PRIORITY JOURNAL; RISK FACTOR; UTERINE CERVIX CANCER; VIRUS TRANSMISSION; WART VIRUS;

EID: 84874760081     PISSN: 00029378     EISSN: 10976868     Source Type: Journal    
DOI: 10.1016/j.ajog.2012.09.007     Document Type: Review

References (71)

1. H. Zur Hausen Condylomata acuminata and human genital cancer Cancer Res 36 1974 794
2. M. Durst, L. Gissmann, H. Ikenberg, H. zur Hausen A papillomavirus DNA from a cervical carcinoma and its prevalence in cancer biopsy samples from different geographic regions Proc Natl Acad Sci USA 80 1983 3812 3815
3. J.L. St Guily, A.C. Jacquard, J.L. Pretet Human papillomavirus genotype distribution in oropharynx and oral cavity cancer in France - the EDiTH VI study J Clin Virol 51 2011 100 104
4. C.M. Wheeler, W.C. Hunt, N.E. Joste, C.R. Key, W.G. Quint, P.E. Castle Human papillomavirus genotype distributions: implications for vaccination and cancer screening in the United States J Natl Cancer Inst 101 2009 475 487
5. J.S. Smith, D.M. Backes, B.E. Hoots, R.J. Kurman, J.M. Pimenta Human papillomavirus type-distribution in vulvar and vaginal cancers and their associated precursors Obstet Gynecol 113 2009 917 924
6. D.M. Backes, R.J. Kurman, J.M. Pimenta, J.S. Smith Systematic review of human papillomavirus prevalence in invasive penile cancer Cancer Causes Control 20 2009 449 457
7. M. Boshart, L. Gissmann, H. Ikenberg, A. Kleinheinz, W. Scheurlen, H. zur Hausen A new type of papillomavirus DNA, its presence in genital cancer biopsies and in cell lines derived from cervical cancer EMBO J 3 1984 1151 1157
8. S.K. Kjaer, B. Chackerian, A.J. van den Brule High-risk human papillomavirus is sexually transmitted: evidence from a follow-up study of virgins starting sexual activity (intercourse) Cancer Epidemiol Biomarkers Prev 10 2001 101 106
9. A.N. Burchell, P.P. Tellier, J. Hanley, F. Coutlee, E.L. Franco Human papillomavirus infections among couples in new sexual relationships Epidemiology 21 2010 31 37
10. M.C. Bleeker, C.J. Hogewoning, J. Berkhof Concordance of specific human papillomavirus types in sex partners is more prevalent than would be expected by chance and is associated with increased viral loads Clin Infect Dis 41 2005 612 620
11. M. Benevolo, M. Mottolese, F. Marandino HPV prevalence among healthy Italian male sexual partners of women with cervical HPV infection J Med Virol 80 2008 1275 1281
12. A.G. Nyitray, L. Menezes, B. Lu Genital human papillomavirus (HPV) concordance in heterosexual couples J Infect Dis 206 2012 202 211
13. A.R. Giuliano, C.M. Nielson, R. Flores The optimal anatomic sites for sampling heterosexual men for human papillomavirus (HPV) detection: the HPV detection in men study J Infect Dis 196 2007 1146 1152
14. B.Y. Hernandez, L.R. Wilkens, X. Zhu Transmission of human papillomavirus in heterosexual couples Emerg Infect Dis 14 2008 888 894
15. R.L. Winer, J.P. Hughes, Q. Feng Condom use and the risk of genital human papillomavirus infection in young women N Engl J Med 354 2006 2645 2654
16. G. Albero, X. Castellsague, A.R. Giuliano, F.X. Bosch Male circumcision and genital human papillomavirus: a systematic review and meta-analysis Sex Transm Dis 39 2012 104 113
17. R.L. Rombaldi, E.P. Serafini, J. Mandelli, E. Zimmermann, K.P. Losquiavo Transplacental transmission of human papillomavirus Virol J 5 2008 106
18. R.L. Rombaldi, E.P. Serafini, J. Mandelli, E. Zimmermann, K.P. Losquiavo Perinatal transmission of human papilomavirus DNA Virol J 6 2009 83
19. X. Castellsague, T. Drudis, M.P. Canadas Human papillomavirus (HPV) infection in pregnant women and mother-to-child transmission of genital HPV genotypes: a prospective study in Spain BMC Infect Dis 9 2009 74
20. M. Thomas, D. Pim, L. Banks The role of the E6-p53 interaction in the molecular pathogenesis of HPV Oncogene 18 1999 7690 7700
21. S.N. Boyer, D.E. Wazer, V. Band E7 protein of human papilloma virus-16 induces degradation of retinoblastoma protein through the ubiquitin-proteasome pathway Cancer Res 56 1996 4620 4624
22. N. Munoz, X. Castellsague, A.B. de Gonzalez, L. Gissmann Chapter 1: HPV in the etiology of human cancer Vaccine 24 Suppl 3 2006 S3/1-10
23. V. Bouvard, R. Baan, K. Straif A review of human carcinogens - part B: biological agents Lancet Oncol 10 2009 321 322
24. S. Hariri, E.R. Unger, M. Sternberg Prevalence of genital human papillomavirus among females in the United States, the National Health And Nutrition Examination Survey, 2003-2006 J Infect Dis 204 2011 566 573
25. J.S. Smith, A. Melendy, R.K. Rana, J.M. Pimenta Age-specific prevalence of infection with human papillomavirus in females: a global review J Adolesc Health 43 4 Suppl 2008 S5 S25 S25.e21-41
26. H. Trottier, S. Ferreira, P. Thomann Human papillomavirus infection and reinfection in adult women: the role of sexual activity and natural immunity Cancer Res 70 2010 8569 8577
27. P. Gonzalez, A. Hildesheim, A.C. Rodriguez Behavioral/lifestyle and immunologic factors associated with HPV infection among women older than 45 years Cancer Epidemiol Biomarkers Prev 19 2010 3044 3054
28. A.R. Giuliano, E. Lazcano-Ponce, L.L. Villa The human papillomavirus infection in men study: human papillomavirus prevalence and type distribution among men residing in Brazil, Mexico, and the United States Cancer Epidemiol Biomarkers Prev 17 2008 2036 2043
29. E.L. Franco, L.L. Villa, A. Ruiz, M.C. Costa Transmission of cervical human papillomavirus infection by sexual activity: differences between low and high oncogenic risk types J Infect Dis 172 1995 756 763
30. C.C. King, D.J. Jamieson, J. Wiener Bacterial vaginosis and the natural history of human papillomavirus Infect Dis Obstet Gynecol 2011 2011 319460
31. D.H. Watts, M. Fazzari, H. Minkoff Effects of bacterial vaginosis and other genital infections on the natural history of human papillomavirus infection in HIV-1-infected and high-risk HIV-1-uninfected women J Infect Dis 191 2005 1129 1139
32. A.B. Moscicki, N. Hills, S. Shiboski Risks for incident human papillomavirus infection and low-grade squamous intraepithelial lesion development in young females JAMA 285 2001 2995 3002
33. T. Anttila, P. Saikku, P. Koskela Serotypes of Chlamydia trachomatis and risk for development of cervical squamous cell carcinoma JAMA 285 2001 47 51
34. M. Lehtinen, K.A. Ault, E. Lyytikainen Chlamydia trachomatis infection and risk of cervical intraepithelial neoplasia Sex Transm Infect 87 2011 372 376
35. I. Silins, W. Ryd, A. Strand Chlamydia trachomatis infection and persistence of human papillomavirus Int J Cancer 116 2005 110 115
36. Tobacco smoke and involuntary smoking IARC Monogr Eval Carcinog Risks Hum 83 2004 1 1438
37. M.M. Byrne, E.P. Davila, W. Zhao Cancer screening behaviors among smokers and non-smokers Cancer Epidemiol 34 2010 611 617
38. J.E. Wilkerson, J.M. Bailey, M.E. Bieniasz, S.I. Murray, M.T. Ruffin Psychosocial factors in risk of cervical intraepithelial lesions J Womens Health (Larchmt) 18 2009 513 518
39. K. Syrjanen, I. Shabalova, N. Petrovichev Smoking is an independent risk factor for oncogenic human papillomavirus (HPV) infections but not for high-grade CIN Eur J Epidemiol 22 2007 723 735
40. S. Vaccarella, R. Herrero, P.J. Snijders Smoking and human papillomavirus infection: pooled analysis of the International Agency for Research on Cancer HPV Prevalence Surveys Int J Epidemiol 37 2008 536 546
41. L.F. Xi, L.A. Koutsky, P.E. Castle Relationship between cigarette smoking and human papilloma virus types 16 and 18 DNA load Cancer Epidemiol Biomarkers Prev 18 2009 3490 3496
42. S. Collins, T.P. Rollason, L.S. Young, C.B. Woodman Cigarette smoking is an independent risk factor for cervical intraepithelial neoplasia in young women: a longitudinal study Eur J Cancer 46 2010 405 411
43. J. Koshiol, J. Schroeder, D.J. Jamieson Smoking and time to clearance of human papillomavirus infection in HIV-seropositive and HIV-seronegative women Am J Epidemiol 164 2006 176 183
44. H. De Vuyst, F. Lillo, N. Broutet, J.S. Smith HIV, human papillomavirus, and cervical neoplasia and cancer in the era of highly active antiretroviral therapy Eur J Cancer Prev 17 2008 545 554
45. H.D. Strickler, R.D. Burk, M. Fazzari Natural history and possible reactivation of human papillomavirus in human immunodeficiency virus-positive women J Natl Cancer Inst 97 2005 577 586
46. L.F. Bratcher, V.V. Sahasrabuddhe The impact of antiretroviral therapy on HPV and cervical intraepithelial neoplasia: current evidence and directions for future research Infect Agent Cancer 5 2010 8
47. H. Richardson, G. Kelsall, P. Tellier The natural history of type-specific human papillomavirus infections in female university students Cancer Epidemiol Biomarkers Prev 12 2003 485 490
48. G.Y. Ho, R. Bierman, L. Beardsley, C.J. Chang, R.D. Burk Natural history of cervicovaginal papillomavirus infection in young women N Engl J Med 338 1998 423 428
49. V. Dalstein, D. Riethmuller, J.L. Pretet Persistence and load of high-risk HPV are predictors for development of high-grade cervical lesions: a longitudinal French cohort study Int J Cancer 106 2003 396 403
50. C. Ferreccio, V. Van De Wyngard, F. Olcay High-risk HPV infection after five years in a population-based cohort of Chilean women Infect Agent Cancer 6 2011 21
51. L.A. Koutsky, K.K. Holmes, C.W. Critchlow A cohort study of the risk of cervical intraepithelial neoplasia grade 2 or 3 in relation to papillomavirus infection N Engl J Med 327 1992 1272 1278
52. J. Bae, S.S. Seo, Y.S. Park Natural history of persistent high-risk human papillomavirus infections in Korean women Gynecol Oncol 115 2009 75 80
53. J.P. Bory, J. Cucherousset, M. Lorenzato Recurrent human papillomavirus infection detected with the hybrid capture II assay selects women with normal cervical smears at risk for developing high grade cervical lesions: a longitudinal study of 3,091 women Int J Cancer 102 2002 519 525
54. P.E. Castle, S. Wacholder, A.T. Lorincz A prospective study of high-grade cervical neoplasia risk among human papillomavirus-infected women J Natl Cancer Inst 94 2002 1406 1414
55. J. Cuzick, M. Arbyn, R. Sankaranarayanan Overview of human papillomavirus-based and other novel options for cervical cancer screening in developed and developing countries Vaccine 26 Suppl 10 2008 K29 K41
56. B.Y. Hernandez, K. McDuffie, L.R. Wilkens, L. Kamemoto, M.T. Goodman Diet and premalignant lesions of the cervix: evidence of a protective role for folate, riboflavin, thiamin, and vitamin B12 Cancer Causes Control 14 2003 859 870
57. R. Siegel, D. Naishadham, A. Jemal Cancer statistics, 2012 CA Cancer J Clin 62 2012 10 29
58. T.C. Wright Jr, L.S. Massad, C.J. Dunton, M. Spitzer, E.J. Wilkinson, D. Solomon 2006 consensus guidelines for the management of women with cervical intraepithelial neoplasia or adenocarcinoma in situ J Low Genit Tract Dis 11 2007 223 239
59. D. Saslow, D. Solomon, H.W. Lawson American Cancer Society, American Society for Colposcopy and Cervical Pathology, and American Society for Clinical Pathology screening guidelines for the prevention and early detection of cervical cancer J Low Genit Tract Dis 16 2012 175 204
60. K. Hoover, A. Friedman, D. Montano, D. Kasprzyk, A. Greek, M. Hogben What about the partners of women with abnormal Pap or positive HPV tests? Sex Transm Dis 36 2009 141 146
61. J. Cuzick, C. Clavel, K.U. Petry Overview of the European and North American studies on HPV testing in primary cervical cancer screening Int J Cancer 119 2006 1095 1101
62. M.H. Mayrand, E. Duarte-Franco, I. Rodrigues Human papillomavirus DNA versus Papanicolaou screening tests for cervical cancer N Engl J Med 357 2007 1579 1588
63. G. Ronco, P. Giorgi-Rossi, F. Carozzi Efficacy of human papillomavirus testing for the detection of invasive cervical cancers and cervical intraepithelial neoplasia: a randomised controlled trial Lancet Oncol 11 2010 249 257
64. M. Leinonen, P. Nieminen, L. Kotaniemi-Talonen Age-specific evaluation of primary human papillomavirus screening vs conventional cytology in a randomized setting J Natl Cancer Inst 101 2009 1612 1623
65. P.E. Castle, M.H. Stoler, T.C. Wright Jr, A. Sharma, T.L. Wright, C.M. Behrens Performance of carcinogenic human papillomavirus (HPV) testing and HPV16 or HPV18 genotyping for cervical cancer screening of women aged 25 years and older: a subanalysis of the ATHENA study Lancet Oncol 12 2011 880 890
66. M. Gok, D.A. Heideman, F.J. van Kemenade HPV testing on self collected cervicovaginal lavage specimens as screening method for women who do not attend cervical screening: cohort study BMJ 340 2010 c1040
67. I.C. Scarinci, F.A. Garcia, E. Kobetz Cervical cancer prevention: new tools and old barriers Cancer 116 2010 2531 2542
68. P. Petignat, D.L. Faltin, I. Bruchim, M.R. Tramer, E.L. Franco, F. Coutlee Are self-collected samples comparable to physician-collected cervical specimens for human papillomavirus DNA testing? A systematic review and meta-analysis Gynecol Oncol 105 2007 530 535
69. K.A. Ault Effect of prophylactic human papillomavirus L1 virus-like-particle vaccine on risk of cervical intraepithelial neoplasia grade 2, grade 3, and adenocarcinoma in situ: a combined analysis of four randomised clinical trials Lancet 369 2007 1861 1868
70. M. Lehtinen, J. Paavonen, C.M. Wheeler Overall efficacy of HPV-16/18 AS04-adjuvanted vaccine against grade 3 or greater cervical intraepithelial neoplasia: 4-year end-of-study analysis of the randomised, double-blind PATRICIA trial Lancet Oncol 13 2012 89 99
71. C.M. Wheeler, X. Castellsague, S.M. Garland Cross-protective efficacy of HPV-16/18 AS04-adjuvanted vaccine against cervical infection and precancer caused by non-vaccine oncogenic HPV types: 4-year end-of-study analysis of the randomised, double-blind PATRICIA trial Lancet Oncol 13 2012 100 110